Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
8.42
+0.49 (6.18%)
At close: Dec 31, 2025, 4:00 PM EST
8.44
+0.02 (0.19%)
After-hours: Dec 31, 2025, 7:59 PM EST
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $85.1 million as of December 31, 2025. Its market cap has decreased by -2.91% in one year.
Market Cap
85.10M
Enterprise Value
-2.47M
1-Year Change
-2.91%
Ranking
Category
Stock Price
$8.42
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $85.10M, a decrease of -71.79%. That is a compound annual growth rate of -21.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |